1.
Fallahpour M, Nabavi M, Ghalehbaghi B, Heydari Ghadikolaii S, Bemanian MH, Jalessi M. Add-on Baricitinib in Omalizumab-refractory Chronic Rhinosinusitis with Nasal Polyps as a Dual-pathway Strategy. Iran J Allergy Asthma Immunol. 2026;:1-5.